L. Daniel Browne, CEO and President at Revance Therapeutics, Inc. (RVNC), sold 12,000 shares at $19.78 ($237K) on 2017-01-25, disclosed to the SEC on 2017-01-27.
Open-market sale of $237k RVNC by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RVNC | SELL | 2018-03-16 | $376K | — | Filing → |
| RVNC | SELL | 2018-03-09 | $1.7M | — | Filing → |
| RVNC | SELL | 2017-11-24 | $190K | — | Filing → |